secwatch.observer — SEC 8-K summary
======================================

Issuer:     STRYKER CORP (SYK)
CIK:        0000310764
Form:       8-K
Filed at:   2022-10-31T23:59:59+00:00
Accession:  0000310764-22-000103
Event type: earnings
Sentiment:  neutral
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Stryker Q3 organic sales +9.9% to $4.5B; adj EPS $2.12 -3.6%; guides FY adj EPS $9.15-$9.25
--------------------------------------------------------------------------------

- Net sales $4.5B (+7.7% reported, +9.9% organic); MedSurg & Neuro +10.8% organic, Ortho & Spine +8.7%.
- Reported EPS $2.14 (+87.7%); adjusted EPS $2.12 (-3.6%); adjusted operating margin 22.3% (-310 bps).
- FY 2022 organic net sales growth guidance raised to 8.5%-9.0%; currency to hit sales ~4% and adj EPS $0.35-$0.40.
- Adjusted EPS guidance narrowed to $9.15-$9.25 from prior view, citing inflation and FX headwinds.
- CEO cites strong capital equipment order book and sales momentum despite product shortages.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/310764/000031076422000103/0000310764-22-000103-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/310764/000031076422000103/syk-20221031.htm
  HTML page:      https://secwatch.observer/filing/0000310764-22-000103

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer